Caspofungin pulses for CPA (chronic pulmonary aspergillosis): A retrospective study

Michele Fernandes (London, United Kingdom), Michele Fernandes, Anand Shah, Sophie Brooks, Emily Grist, Robert Wilson, Michael Loebinger

Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Michele Fernandes (London, United Kingdom), Michele Fernandes, Anand Shah, Sophie Brooks, Emily Grist, Robert Wilson, Michael Loebinger. Caspofungin pulses for CPA (chronic pulmonary aspergillosis): A retrospective study. Eur Respir J 2016; 48: Suppl. 60, 2643

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA).
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Voriconazole (VORI) for proven chronic pulmonary aspergillosis (CPA): a prospective multicenter trial
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG)
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005

Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012


Breakthrough invasive pulmonary aspergillosis (IPA) in patients receiving posaconazole prophylaxis (PPxis)
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008



Chronic pulmonary aspergillosis: Characteristics of 30 nonimmunocompromised patients
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

Invasive pulmonary aspergillosis in immunosuppressed patients
Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections
Year: 2015



Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Source: Eur Respir J 2011; 37: 865-872
Year: 2011



Omalizumab and voriconazole in allergic broncopulmonary aspergillosis (A case series)
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011

A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018
Year: 2018



Interferon-γ therapy in two patients with progressive chronic pulmonary aspergillosis
Source: Eur Respir J 2006; 27: 1307-1310
Year: 2006



Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015

Clinical characteristics of chronic pulmonary aspergillosis and colonization; retrospective analysis of patients with isolation of asperguillus species from respiratory samples
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014